INS and obesity due to melanocortin 4 receptor deficiency: As one of the most common side effects of insulin treatment remains significant weight gain, combining it with leptin-neutralizing antibodies would restore leptin sensitivity and prove beneficial for the management of obesity in type 2 DM [135].